HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cardiology
Heart disease and cancer death rates studied in US adults aged 45-64 from 1999 to 2018
U.S. study tracks heart disease and cancer death rates in middle-aged adults
An observational study examined heart disease and cancer death rates among US men and women aged 45-64 years from 1999 to 2018.
A U.S. study tracked heart disease and cancer death rates in middle-aged adults from 1999 to 2018, but the final results were not reported.
CDC
Apr 2, 2026
Oncology
Sys. Review
PAI-1 inhibition shows preclinical promise; elevated levels linked to poor cancer prognosis
Could a common cancer protein become a new treatment target?
A systematic review found elevated plasminogen activator inhibitor-1 (PAI-1) levels are consistently associated with poor prognosis across s…
High levels of a protein called PAI-1 signal worse outcomes in several cancers, while early lab studies suggest blocking it could help fight…
Frontiers
Apr 2, 2026
Cardiology
Report examines cardiovascular health and predicted heart age in US cancer survivors
Researchers examine cardiovascular health and heart age in US cancer survivors
An observational report describes cardiovascular health and predicted heart age in cancer survivors in the United States.
A new report examines predicted heart age among US cancer survivors to understand their cardiovascular health challenges.
CDC
Apr 2, 2026
Allergy & Immunology
Sys. Review
Systematic review describes polysaccharide mechanisms and structure-activity relationships for anti-cancer effects
Review explores how natural polysaccharides may work against cancer in lab studies
A systematic review summarizes preclinical research on natural polysaccharides, describing multi-target anti-cancer mechanisms including imm…
Natural plant sugars might fight cancer by boosting immune cells, triggering tumor death, and stopping blood vessel growth in lab tests.
Frontiers
Apr 2, 2026
Oncology
RCT
Home treatment for low-risk cancer-associated PE shows 4.6% major bleeding rate in ONCO PE companion report
Could some cancer patients safely treat blood clots at home? New research suggests yes
A predetermined companion report from the ONCO PE trial evaluated 3-month outcomes for home vs.
Active cancer patients with low-risk lung clots can safely take blood thinners at home, avoiding disruptive hospital stays while staying on …
Mar 30, 2026
Oncology
Meta-analysis
Meta-analysis: 42% palliative care utilization among Ethiopian cancer patients; education, male gender associated
In Ethiopia, less than half of cancer patients get the care they need to manage pain and symptoms
A systematic review and meta-analysis of 9 cross-sectional studies involving 2,839 cancer patients in Ethiopia found a pooled palliative car…
In Ethiopia, only 42% of cancer patients receive pain and symptom relief, with men and educated individuals far more likely to get this esse…
Mar 30, 2026
Oncology
RCT
TrialTalk communication method boosts clinical trial consent rates to 92.9% vs 82.4% in pilot RCT
Could a better conversation help more cancer patients consider clinical trials?
In a pilot RCT, oncologists trained in the TrialTalk structured communication method had patients who were significantly more likely to cons…
A simple conversation tool helps trained doctors get nearly 93% of cancer patients to sign consent forms for clinical trials.
Mar 30, 2026
Oncology
RCT
Guided Breathing VR Reduces Opioid Use Post-PTBD in Cancer Patients by 64%
Can Virtual Reality and Breathing Techniques Reduce Cancer Pain?
In a randomized trial, guided breathing VR (VRBG) significantly reduced opioid use post-PTBD compared to conventional VR (VROG), with a mean…
Cancer patients using virtual reality with guided breathing took significantly less pain medication after a painful procedure than those usi…
Mar 27, 2026